Thursday, November 14, 2024 7:20:34 PM
exwannabe,
One tumor injected and when immune response caused sufficient enlargement from this then treatment was stopped due to pseudoprogression being labeled progression. Also, some tumors simply became totally necrotic and were later surgically removed. A pancreatic cancer patient saw this happen and perhaps the sarcoma patient that had a huge tumor simply collapse if I recall correctly and one lung cancer patient went back to swimming after treatment.
When tumors are stopped from growing they die from the inside out. Distal tumors also were affected in some cases by Direct indicating some systemic effect. Those distant tumors were not treated directly which is the necessary part of treatment with Direct in order to pick up all antigen targets in each heterogenous tumor to prevent escape. You know this; ). Best wishes.
One tumor injected and when immune response caused sufficient enlargement from this then treatment was stopped due to pseudoprogression being labeled progression. Also, some tumors simply became totally necrotic and were later surgically removed. A pancreatic cancer patient saw this happen and perhaps the sarcoma patient that had a huge tumor simply collapse if I recall correctly and one lung cancer patient went back to swimming after treatment.
When tumors are stopped from growing they die from the inside out. Distal tumors also were affected in some cases by Direct indicating some systemic effect. Those distant tumors were not treated directly which is the necessary part of treatment with Direct in order to pick up all antigen targets in each heterogenous tumor to prevent escape. You know this; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
